The nation's biggest pharmacy benefits manager is muscling back into the debate over soaring drug costs by promoting a less-expensive alternative to a life-saving medicine with a list price of $750 ...
Celltrion said on the 16th that its cancer drugs and autoimmune disease treatments are expanding both market share and prescriptions in major European countries. The cancer drug "Vegzelma" ...
SOME OF THE FINANCIAL TOLL. LAURA, THANK YOU. WELL, NEW AT FOUR, AN IOWA BASED PHARMACY IS ACCUSED OF SELLING FAKE OZEMPIC TO A MICHIGAN COMPANY, ACCORDING TO A LAWSUIT FILED IN WASHINGTON COUNTY.
Los Angeles isn’t ending homelessness — it’s financing it, spending $418 million in 2025 with just 10% of that going toward getting people permanently off the streets. A bombshell City Hall report ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
The Federal Trade Commission said it has reached a settlement with Express Scripts, resolving an earlier lawsuit that alleged the pharmacy benefit manager artificially inflated insulin drug prices.
PISCATAWAY, N.J., Jan. 28, 2026 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life science research and biotech solutions, today announced its supporting role in the experimental ...
Grocery chain Albertsons, which offers pharmacies, is suing the Cigna-owned pharmacy benefit manager Express Scripts for at least $10.9 million over alleged prescription underpayments, according to a ...
Pittsburgh-based insurer Highmark is further expanding its drug offerings through CivicaScript and leaning on biosimilars as pharmaceutical costs continue to rise for many. Highmark is a founding ...
Windows security updates tend to conjure thoughts of operating system vulnerabilities, including zero-days, being patched or even unexpected failures with serious consequences. This security update, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results